Emori, T., Itonaga, M., Ashida, R., Tamura, T., Kawaji, Y., Hatamaru, K., . . . Kitano, M. (2022). Impact of sarcopenia on prediction of progression-free survival and overall survival of patients with pancreatic ductal adenocarcinoma receiving first-line gemcitabine and nab-paclitaxel chemotherapy. Pancreatology, 22(2), 277-285. https://doi.org/10.1016/j.pan.2021.12.013

Emori, Tomoya, et al. "Impact of Sarcopenia on Prediction of Progression-free Survival and Overall Survival of Patients with Pancreatic Ductal Adenocarcinoma Receiving First-line Gemcitabine and Nab-paclitaxel Chemotherapy." Pancreatology 22, no. 2 (2022): 277-285. https://doi.org/10.1016/j.pan.2021.12.013.

Emori, Tomoya, et al. "Impact of Sarcopenia on Prediction of Progression-free Survival and Overall Survival of Patients with Pancreatic Ductal Adenocarcinoma Receiving First-line Gemcitabine and Nab-paclitaxel Chemotherapy." Pancreatology, vol. 22, no. 2, 2022, pp. 277-285, https://doi.org/10.1016/j.pan.2021.12.013.